Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2017
Source ID
10.1016/j.neuroimage.2017.06.070

Entities

People

  • Aldo Cordova-palomera
  • Andreas Engvig
  • Anne Brækhus
  • Dag Alnæs
  • Geir Selbæk
  • Ingrid Agartz
  • Jan Egil Nordvik
  • Karin Persson
  • Knut Engedal
  • Krystal Zaske
  • Lars T. Westlye
  • Maria Lage Barca
  • Martina Jonette Lund
  • Nhat Trung Doan
  • Ole A. Andreassen
  • Tobias Kaufmann
  • Torgeir Moberget

Organizations

  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson
  • Kristian Gerhard Jebsen Foundation
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Pfizer
  • Research Council of Norway
  • Roche (United States)
  • Seventh Framework Programme
  • Southern and Eastern Norway Regional Health Authority
  • Takeda Pharmaceutical Company
  • United States Department of Defense